Theravance Biopharma
TBPH
TBPH
128 hedge funds and large institutions have $422M invested in Theravance Biopharma in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 15 closing their positions.
Holders
128
Holders Change
+9
Holders Change %
+7.56%
% of All Funds
1.7%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
24
Increased
43
Reduced
33
Closed
15
Calls
$11K
Puts
$3K
Net Calls
+$8K
Net Calls Change
+$112K
Top Buyers
1 |
NM
1
Newtyn Management
New York
|
$44.8M |
2 |
2
UBS Group
Zurich,
Switzerland
|
$1.64M |
3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$5.21M |
4 |
4
Millennium Management
New York
|
$1.81M |
5 |
5
Citadel Advisors
Miami,
Florida
|
$2.96M |